Seray Saray

7PUBLICATIONS
72CO-AUTHORS
Molecular targetsPredictive and prognostic markersChemotherapyAutoimmunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 28, 2026
Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group.

Sedat Yıldız, Hacer Demir, Talha Özüdoğru

|Oct 22, 2025
Expression of gamma-aminobutyric acid type A receptor subunit π and minichromosome maintenance-3 in breast cancer patients treated with neoadjuvant chemotherapy: a target molecule or a proliferation marker?

Yakup İriagac, Meltem Oznur, Eyyup Çavdar

|Sep 03, 2025
Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study.

Ogur Karhan, Serdar İleri, Zuhat Urakçı

|Aug 28, 2025
Androgen Receptor: Clinical Importance in Breast Cancer Patients Receiving CDK 4/6 Inhibitor Treatment.

Seray Saray, Tufan Yılmaz, Hüseyin Kanmaz

|Aug 28, 2025
Comparison of Frontline FOLFIRINOX with Fluorouracil-Based and Gemcitabine-Based Chemotherapies in Metastatic Ampullary Adenocarcinoma: A Multicenter Study by the Turkish Oncology Group (TOG).

Ali Kalem, Tulay Kus, Savas Gokcek

|Jul 27, 2023
Case report: Drug-induced vitiligo during treatment with BRAF/MEK inhibitors in a patient with metastatic conjunctival melanoma.

Seray Saray, Pelin Hızlı

Pageof 2

Frequent Collaborators

2 joint publications

Yakup İriağaç

2 joint publications

Berkan Karabuga

1 joint publications

Ozlem Ozdemir

1 joint publications

Baha Zengel